Reference
Wahid B. Hepatotoxicity and virological breakthrough of HCV following treatment with sofosbuvir, daclatasvir, and ribavirin in patients previously treated for tuberculosis. Journal of Medical Virology 91: 2195-2197, No. 12, Dec 2019. Available from: URL: http://doi.org/10.1002/jmv.25557 - Pakistan
Rights and permissions
About this article
Cite this article
Antituberculars/antivirals. Reactions Weekly 1783, 50 (2019). https://doi.org/10.1007/s40278-019-72533-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-72533-6